Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram

被引:24
|
作者
Potts, A. L.
Young, K. L.
Carter, B. S.
Shenai, J. P.
机构
[1] Vanderbilt Childrens Hosp, Div Neonatol, Dept Pediat, Nashville, TN 37232 USA
[2] Vanderbilt Childrens Hosp, Dept Pharm, Nashville, TN USA
[3] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
关键词
necrotizing enterocolitis; SSRI; antidepressant; newborn; breastmilk;
D O I
10.1038/sj.jp.7211640
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described.
引用
收藏
页码:120 / 122
页数:3
相关论文
共 50 条
  • [21] Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
    Nordeng, H
    Lindemann, R
    Perminov, KV
    Reikvam, Å
    ACTA PAEDIATRICA, 2001, 90 (03) : 288 - 291
  • [22] In Utero Exposure to Selective Serotonin Reuptake Inhibitors: Evidence for Poor Neonatal Adaptation
    Moulsdale, Wendy
    Hermann, Susan
    NEWBORN AND INFANT NURSING REVIEWS, 2008, 8 (03) : 123 - 130
  • [23] In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
    Nicole B. Gidaya
    Brian K. Lee
    Igor Burstyn
    Michael Yudell
    Erik L. Mortensen
    Craig J. Newschaffer
    Journal of Autism and Developmental Disorders, 2014, 44 : 2558 - 2567
  • [24] BREAST-MILK AND NECROTIZING ENTEROCOLITIS
    DUGDALE, AE
    LANCET, 1991, 337 (8738): : 435 - 435
  • [25] Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study
    Guiard, Bruno P.
    El Mansari, Mostafa
    Murphy, Dennis L.
    Blier, Pierre
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (03): : 349 - 361
  • [26] Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy
    Pae, Chi-Un
    Serretti, Alessandro
    Mandelli, Laura
    De Ronchi, Diana
    Patkar, Ashwin A.
    Jun, Tae-Youn
    Kim, Jung-Jin
    Lee, Chang-Uk
    Lee, Soo-Jung
    Lee, Chul
    Paik, In-Ho
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (01): : 69 - 75
  • [27] Platelet Serotonin in Newborns and Infants: Ontogeny, Heritability, and Effect of In Utero Exposure to Selective Serotonin Reuptake Inhibitors
    George M Anderson
    Kathryn Czarkowski
    Norman Ravski
    C Neill Epperson
    Pediatric Research, 2004, 56 : 418 - 422
  • [28] Platelet serotonin in newborns and infants:: Ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors
    Anderson, GM
    Czarkowski, K
    Ravski, N
    Epperson, CN
    PEDIATRIC RESEARCH, 2004, 56 (03) : 418 - 422
  • [29] The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning
    Brown, Holden D.
    Amodeo, Dionisio A.
    Sweeney, John A.
    Ragozzino, Michael E.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (11) : 1443 - 1455
  • [30] Portal infusion of the selective serotonin reuptake inhibitor escitalopram enhances hepatic glucose disposal in vivo
    An, Zhibo
    Moore, Mary C.
    Winnick, Jason J.
    Lautz, Margaret
    Farmer, Ben
    Neal, Doss
    Allen, Eric
    Hastings, Jon
    Cherrington, Alan D.
    DIABETES, 2007, 56 : A394 - A394